Price target
26.470.000.00%
The 7 analysts offering 1 year price forecasts for NEU have a max estimate of — and a min estimate of —.
Analyst rating
Based on 7 analysts giving stock ratings to NEU in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
NEU EPS for the last quarter is 0.06 AUD despite the estimation of 0.11 AUD. In the next quarter EPS is expected to reach 0.98 AUD. Track more of NEUREN PHARMACEUTICALS LIMITED financials and stay on top of what is up with the company.
In the next quarter NEUREN PHARMACEUTICALS LIMITED revenue is expected to reach 182.22 M AUD. Check out NEUREN PHARMACEUTICALS LIMITED revenue and earnings and make informed decisions.
According to analysts, NEU price target is 26.47 AUD with a max estimate of 30.94 AUD and a min estimate of 19.00 AUD. Check if this forecast comes true in a year, meanwhile watch NEUREN PHARMACEUTICALS LIMITED stock price chart and keep track of the current situation with NEU news and stock market news.
We've gathered opinions of 7 analysts rating NEU stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.